# Smoking Cessation Intervention for Thoracic Patients

> **NCT00580398** · PHASE1,PHASE2 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 49 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **BEHAVIORAL:** Smoking cessation counseling
- **DRUG:** varenicline

## Key facts

- **NCT ID:** NCT00580398
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2018-10-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00580398

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00580398, "Smoking Cessation Intervention for Thoracic Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00580398. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*